. Mupp1 promotes endothelial junction stability and Syx-depleted cells exhibit increased VE-cadherin endocytosis. (A) Effect of silencing either Syx or Mupp1 with two nonoverlapping shRNAs, each on the junctional localization of ZO1 in confluent HUVEC monolayers. (B) Silencing efficacy of the mupp1 shRNA constructs in HUVECs. (C) Effect of silencing endogenous Syx or Mupp1 on the localization of ZO1 and VE-cadherin in HMVECs. (D) Effect of silencing endogenous Syx on the internalization of VE-cadherin (VE-cad), as monitored by the uptake of anti-VE-cadherin antibody (BV6; 37°C for 30 min) and its colocalization with the early endosome marker EEA1 in HUVECs, and subsequent acid wash (see Materials and methods). The dotted box is magnified to the right. pLKO NT denotes control nontarget shRNA. (E) Quantification of internalized VE-cadherin fluorescence intensity using ImageJ (means ± SD, n = 9; *, P < 0.01). (Plekhg5) showing the location and the sequence of the region containing the three potential phosphorylation sites identified by mass spectrometry; underlined sites conform to a PKD phosphorylation motif (Döppler et al., 2005) , and the phosphorylatable serines are shown in red. (J) Immunoblot of HeLa cells expressing YFP-tagged Syx in which one of three potential phosphorylation sites was mutated from serine to alanine. Only the replacement of S 806 abolished detection with the pMotif antibody. Accession numbers (obtained from the GenBank), theoretical size (in kilodaltons), and peptide count (unique versus total) of all proteins were identified by mass spectrometry (see Materials and methods) to coimmunoprecipitate with YFP-Syx in HeLa cells.
